Definitive classification generally requires demonstration of a pathognomonic gene rearrangement by molecular methods, i.e., commonly FISH (EWSR1 break-apart), RT-PCR for specific fusion transcripts, or targeted next-generation sequencing panels that detect a broad range of sarcoma fusions. Here, EWSR1 is linked to sarcoma.